chr1-226977523-G-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The ENST00000366777.4(COQ8A):āc.730G>Cā(p.Gly244Arg) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00112 in 1,557,078 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000366777.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COQ8A | NM_020247.5 | c.730G>C | p.Gly244Arg | missense_variant, splice_region_variant | 5/15 | ENST00000366777.4 | NP_064632.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ8A | ENST00000366777.4 | c.730G>C | p.Gly244Arg | missense_variant, splice_region_variant | 5/15 | 1 | NM_020247.5 | ENSP00000355739 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000437 AC: 69AN: 157782Hom.: 0 AF XY: 0.000488 AC XY: 41AN XY: 84072
GnomAD4 exome AF: 0.00120 AC: 1679AN: 1404896Hom.: 4 Cov.: 31 AF XY: 0.00118 AC XY: 816AN XY: 693476
GnomAD4 genome AF: 0.000453 AC: 69AN: 152182Hom.: 0 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74338
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | COQ8A: BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 244 of the COQ8A protein (p.Gly244Arg). This variant also falls at the last nucleotide of exon 5, which is part of the consensus splice site for this exon. This variant is present in population databases (rs199619932, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with COQ8A-related conditions. ClinVar contains an entry for this variant (Variation ID: 439390). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 29, 2023 | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene. (http://gnomad.broadinstitute.org) Computational tools yielded predictions that this variant may interfere with normal RNA splicing. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 27, 2017 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 21, 2022 | The c.730G>C (p.G244R) alteration is located in exon 5 (coding exon 4) of the COQ8A gene. This alteration results from a G to C substitution at nucleotide position 730, causing the glycine (G) at amino acid position 244 to be replaced by an arginine (R). Based on data from gnomAD, the C allele has an overall frequency of 0.04% (80/189108) total alleles studied. The highest observed frequency was 0.09% (68/75612) of European (non-Finnish) alleles. This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autosomal recessive ataxia due to ubiquinone deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 20, 2021 | The p.Gly244Arg variant (rs199619932) has not been reported in the medical literature, is not listed in gene-specific variant databases, nor has it been previously identified in our laboratory. It is listed in the Genome Aggregation Database (gnomAD) browser with a frequency in non-Finnish European populations of 0.086% (identified in 62 out of 72,122 chromosomes). The glycine at codon 244 is highly conserved considering 13 species up to C. elegans (Alamut software v2.9), although computational analyses return mixed results regarding the effect of this variant on COQ8A protein structure/function (SIFT: tolerated, PolyPhen2: benign, and Mutation Taster: disease causing). Additionally, this variant affects the last nucleotide of exon 5, and is computationally predicted to alter splicing at this junction (Alamut software v2.9). However, in the absence of mRNA studies, such predictions are not sufficient to assign pathogenicity. Therefore, based on the available information, the clinical significance of the p.Gly244Arg variant cannot be determined with certainty. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at